Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

KRYS

Krystal Biotech (KRYS)

Krystal Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KRYS
DateTimeSourceHeadlineSymbolCompany
05/23/20224:20PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
05/20/20228:27AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
05/19/20227:30PMGlobeNewswire Inc.Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
05/10/20226:25AMTipRanksKrystal Biotech (KRYS) Receives a Buy from H.C. WainwrightNASDAQ:KRYSKrystal Biotech Inc
05/09/20224:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
05/09/20224:15PMGlobeNewswire Inc.Krystal Biotech Announces First Quarter 2022 Financial Results and Reports Updates on Operational ProgressNASDAQ:KRYSKrystal Biotech Inc
05/09/20224:10PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KRYSKrystal Biotech Inc
05/03/20227:00AMGlobeNewswire Inc.Krystal Biotech to Participate in Bank of America Merrill Lynch Global Healthcare ConferenceNASDAQ:KRYSKrystal Biotech Inc
04/28/20227:00AMGlobeNewswire Inc.Jeune Aesthetics Announces Formation and Members of Scientific Advisory BoardNASDAQ:KRYSKrystal Biotech Inc
04/11/20227:00AMGlobeNewswire Inc.Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension StudyNASDAQ:KRYSKrystal Biotech Inc
04/07/20224:19PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KRYSKrystal Biotech Inc
04/07/20224:15PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KRYSKrystal Biotech Inc
03/28/20224:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
03/28/202211:00AMGlobeNewswire Inc.Krystal Biotech Announces Publication of Phase 1 and 2 Clinical Trial (GEM 1/2 Study) of Beremagene Geperpavec (B-VEC) Data in Nature MedicineNASDAQ:KRYSKrystal Biotech Inc
03/28/202210:15AMTipRanksKrystal Biotech (KRYS) Received its Third Buy in a RowNASDAQ:KRYSKrystal Biotech Inc
03/26/202212:00PMGlobeNewswire Inc.New GEM-3 Phase 3 Results for B-VEC Presented at 2022 American Academy of Dermatology Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
03/24/20227:00AMGlobeNewswire Inc.Krystal Biotech to Participate in H.C. Wainwright and Guggenheim Investor ConferencesNASDAQ:KRYSKrystal Biotech Inc
03/23/20225:07AMTipRanksChardan Capital Reiterates a Buy Rating on Krystal Biotech (KRYS)NASDAQ:KRYSKrystal Biotech Inc
03/22/20226:55PMTipRanksKrystal Biotech (KRYS) Gets a Buy Rating from Chardan CapitalNASDAQ:KRYSKrystal Biotech Inc
03/22/20224:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
03/22/202212:25PMTipRanksKrystal Biotech (KRYS) Receives a Buy from H.C. WainwrightNASDAQ:KRYSKrystal Biotech Inc
03/18/20227:00AMGlobeNewswire Inc.Krystal Biotech to Present at 2022 American Academy of Dermatology Annual MeetingNASDAQ:KRYSKrystal Biotech Inc
03/15/20227:00AMGlobeNewswire Inc.Krystal Biotech Announces Settlement with PeriphaGen, Inc.NASDAQ:KRYSKrystal Biotech Inc
02/28/20225:28PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KRYSKrystal Biotech Inc
02/28/20227:33AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:KRYSKrystal Biotech Inc
02/28/20227:00AMGlobeNewswire Inc.Krystal Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Update on Operational ProgressNASDAQ:KRYSKrystal Biotech Inc
02/24/20227:00AMGlobeNewswire Inc.Krystal Biotech to Participate in Cowen’s 42nd Annual Health Care ConferenceNASDAQ:KRYSKrystal Biotech Inc
02/14/20225:40PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KRYSKrystal Biotech Inc
02/14/20225:10PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KRYSKrystal Biotech Inc
02/09/20229:26AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KRYSKrystal Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:KRYS